Non formal social pedagogical work at Srednja zdravstvena šola Celje

z medsebojnim obvešèanjem o strokovnih sreèanjih in izmenjavo veterinarske zakonodaje.

The article stresses the point that the motivation for the enrolment to the Srednja zdravstvena šola Celje among regular and adult students varies.

Appendix No 5 to the Rules on the "Hitra srečka" game of chance

At a somewhat more distant locality at Srednja Kanomlja they were about 100 times lower.

13 Splichal, Slavko 1992: 'Izgubljene utopije'/'Lost utopias', Znanstveno in publicistično središče, Ljubljana, p. 35.

The essay Religion and Politics by Srečo Dragoš looks into the presence of the Roman-Catholic Church in the media coverage of the election campaign.

bizeljsko-sremiški vinorodni okoliš, vinorodni okoliš Bela krajina, vinorodni okoliš Dolenjska and the areas under vines in the regions not included in point 5(d)"

"I always consider footballing logic alone, while the lads I have around me never fail to give their all, and I trust them 100 per cent," is Prince Srečko's simple answer.

ljutomersko-ormoški vinorodni okoliš, mariborski vinorodni okoliš, radgonsko-kapelski vinorodni okoliš, šmarsko-virštajnski vinorodni okoliš, vinorodni okoliš Haloze, prekmurski vinorodni okoliš, vinorodni okoliš Srednje Slovenske gorice, in the Posavje region:

The first shocks from Srečko Katanec and his battlers came in the qualifiers for Euro 2000 and their appearances in the finals, while the last act of the fairytale, which proved that it was no fluke, came in the unforgettable play-offs for the first World Cup of the new millennium.

These are the coordinates of space and time that have born this extremely sexist, chauvinistic, xenophobic and racist discourse which should be understood as a continuation of the genocide in Bosnia using different means, or even as a parallel process accompanying events of this kind, as was Srebrenica for example.

In Serbia, the brothers Bogoljub and Sreten Karić are the owners of a television station with national coverage which also broadcasts via satellite; they own a radio station and several magazines, and through the Astra company, they are the owners of a cellular network operator, construction companies, a bank, a college etc.

It was then that a newcomer in the dugout started writing a success story for the previously distinctly average Slovenia team (they managed a solitary point in the qualifying for France 98), a man who alongside Brane Oblak, Vili Ameršek and Danilo Popivoda was one of a legendary quartet of Slovenian football stars: Srečko Katanec.

Substances and preparations covered by "Seznam registriranih fitofarmacevtskih sredstev v Republiki Sloveniji" (Uradni list RS, št. 31/01, str. 3393, št. 70/01, str. 7317 in št. 94/01, str. 9193) issued periodically by the Minister for Agriculture, Forestry and Food pursuant to Article 28 of the Plant protection products Act (Zakon o fitofarmacevtskih sredstvih, Uradni list št. 11/01, str. 1163).

2 A. Finžgar: 'Odgovornost sredstev množičnega obveščanja zlasti tiska pri posegih v osebne in poslovne pravne položaje'/'The responsibility of the mass media, especially the press, when intervening in legal individual and business positions', Zbornik znanstvenih razprav Pravne fakultete v Ljubljani, 1972, p. 108, (Collection of scientific debates published by the Faculty of Law in Ljubljana, 1972).

Srearyl and cetyl alcohol

box 4 shall contain the words “replacement certificate” or “certificat de remplacement”, as well as the date of issue of the original certificate of origin Form A and its serial number,

Any SRE (+TIH)

SRE relative risk

Median time to SRE (days)

N Proportion of patients with SREs (%)

All Skeletal Related Events (SREs) Placebo Bondronat 6 mg p-value n=158 n=154

All Skeletal Related Events (SREs) Placebo Bondronat 50 mg p-value n=277 n=287

The SRE rate (events/ person year) was 0.628 for Zometa and 1.096 for placebo.

This was a composite endpoint which had the following skeletal related events (SREs) as sub-components:

"Are", "Bre" or "Sre" for belts with retractors and energy-absorption devices on at least one anchorage."

Multiple event analysis showed a 36 % risk reduction in developing SREs in the Zometa group compared with placebo.

Multiple event analysis showed 30.7 % risk reduction in developing SREs in the Zometa group compared with placebo.

The results demonstrated that Zometa 4 mg showed comparable efficacy to 90 mg pamidronate in the prevention of SREs.

Zometa reduced the risk of SREs by 41 % in a multiple event analysis (risk ratio=0.59, p=0.019) compared with placebo.

In a second study including solid tumours other than breast or prostate cancer, Zometa 4 mg significantly reduced the proportion of patients with an SRE, delayed the median time to first SRE by > 2 months, and reduced the skeletal morbidity rate.

Zometa 4 mg significantly reduced the proportion of patients experiencing at least one skeletal related event (SRE), delayed the median time to first SRE by > 5 months, and reduced the annual incidence of events per patient - skeletal morbidity rate.

There was also a 38 % reduction in the risk of developing an SRE for Bondronat treated patients when compared with placebo (relative risk 0.62, p=0.003).

The proportion of patients with at least one SRE (excluding hypercalcaemia) was 29.8 % in the Zometa-treated group versus 49.6 % in the placebo group (p=0.003).

Pooled data from these studies demonstrated a significant advantage for Bondronat 50 mg p. o. over placebo in the reduction in SREs measured by the SMPR (p=0.041).

The number of SREs was also significantly reduced with Bondronat 6 mg and there was a 40 % reduction in the risk of a SRE over placebo (relative risk 0.6, p = 0.003).

Median time to onset of the first SRE was not reached in the Zometa-treated arm at the end of the study and was significantly prolonged compared to placebo (p=0.007).

Data from this study demonstrated a significant advantage for intravenous Bondronat 6 mg over placebo in the reduction in SREs measured by the time-adjusted SMPR (p=0.004).

Zometa was also studied in a double-blind, randomised, placebo-controlled trial in 228 patients with documented bone metastases from breast cancer to evaluate the effect of Zometa on the skeletal related event (SRE) rate ratio, calculated as the total number of SRE events (excluding hypercalcaemia and adjusted for prior fracture), divided by the total risk period.

8 Clinical trial results in the prevention of skeletal related events in patients with advanced malignancies involving bone The first randomised, double-blind, placebo-controlled study compared Zometa to placebo for the prevention of skeletal related events (SREs) in prostate cancer patients.